ImpriMed, founded in 2017 in Silicon Valley, is a leading precision medicine startup revolutionizing cancer treatment with artificial intelligence. The company’s pioneering drug response prediction technology helps reduce costs, accelerate treatment, enhance efficacy, and improve the quality of life for patients. To date, the company’s technology has been deployed across more than 40 U.S. states, and 17,000+ canine and feline blood cancer tests have been performed as of 2024. ImpriMed is now poised to extend its groundbreaking AI-driven approach to human healthcare, redefining the future of oncology treatment with personalized, effective solutions. For additional information, visit www.imprimedicine.com.
Company Details
- Employees
- 42
- Founded
- -
- Address
- 1130 Independence Ave, Mountain View,california 94043,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- imprimedicine.com
- Keywords
- Precision Medicine, Veterinary Medicine, Artificial Intelligence, Biotechnology, Animal Health, Machine Learning, Canine Lymphoma.
- HQ
- Mountain View, California
Imprimed, Inc. Questions
Imprimed, Inc.'s website is imprimedicine.com
Imprimed, Inc.'s LinkedIn profile is https://www.linkedin.com/company/imprimed-inc
Imprimed, Inc. has
42 employees.
View email and phone details for 42
employees at Imprimed, Inc..
Imprimed, Inc.'s industry is
Biotechnology Research
Imprimed, Inc.'s top competitors are
Zoetis,
Imprimedkorea,
Dynocardia, Inc.,
Northrop Grumman,
Petdx,
Fidocure®,
Untangled,
Ascent Autism,
Natera,
Biotia.
Imprimed, Inc.'s categories are Biotechnology Research
Imprimed, Inc.'s founding year is 2017
